Physician profile
Michael Hong
NPI 1336342369
$24,234.04
in general payments reported to CMS, 2019-2025
22 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,538 · 2020: $404 · 2021: $74.31 · 2022: $549 · 2023: $858 · 2024: $3,085 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $3,401 · Consulting Fee: $825 · Travel and Lodging: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $14,000.00 |
| Food and Beverage | $3,401.12 |
| Consulting Fee | $825.00 |
| Travel and Lodging | $442.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14,094.84 | 2023-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Nit-Vu |
| Medtronic Vascular, INC. | $3,616.88 | 2019 | |
| Stryker Corporation | $1,511.71 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Boston Scientific Corporation | $959.42 | 2019-2025 | Jetstream Sc, Ranger, Opticross 35 |
| Shockwave Medical, INC | $934.52 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $648.48 | 2019-2025 | Supera, Starclose Se, Jeti |
| Medtronic, INC. | $459.40 | 2022-2025 | Venaseal, Solitaire X, Closurefast |
| Janssen Pharmaceuticals, INC | $346.61 | 2019-2024 | Xarelto |
| Philips North America LLC | $336.58 | 2019-2025 | (Az7) Lasers, (9281) Turbo Elite, IV Other |
| Silk Road Medical, INC. | $277.20 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Bard Peripheral Vascular, INC. | $193.76 | 2020-2024 | |
| Cook Medical LLC | $175.48 | 2024-2025 | Rosen, Tornado, Zilver Ptx |
| Inari Medical, INC. | $173.59 | 2020-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| E.R. Squibb & Sons, L.L.C. | $136.90 | 2020-2022 | |
| Amgen INC. | $125.00 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $70.16 | 2022-2025 | Artegraft Vascular Graft, Tyke, Patch, Pledget and Intracardiac |
| Reflow Medical INC | $51.17 | 2024-2025 | |
| Biotronik INC. | $43.01 | 2024 | Passeo-18 |
| Becton, Dickinson and Company | $24.30 | 2024 | Venclose Maven Catheter |
| Terumo Medical Corporation | $24.12 | 2020 | |
| Siemens Medical Solutions USA, INC. | $16.20 | 2019 | |
| Asahi Intecc USA, INC. | $14.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.